Arzeda vs Scala Biodesign
Arzeda vs Scala Biodesign, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Arzeda is on 61/100 and Scala Biodesign on 56/100.
Where each one leads
Arzeda
- our overall score: 61/100 against 56/100
- agent readiness: 64/100 against 45/100
- domain rating: 39/100 against 23/100
- headcount: 74 against 30
- funding raised: $60.0M against $21.5M
- LinkedIn following: 8,740 against 5,945
Scala Biodesign
- headcount growth: +49.4% against +29.2%
At a glance
| Measure | Arzeda | Scala Biodesign |
|---|---|---|
| What it is | Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling. | Designs proteins with superior properties using computational analysis, evolutionary insights, and AI. |
| Category | Biotech, AI-Driven Protein Design, Computational Biology, Enzyme Engineering | Life Sciences, Biotech, Protein, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2008 | 2021 |
| Headquarters | Seattle, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Arzeda | Scala Biodesign |
|---|---|---|
| Employees | 74 | 30 |
| Headcount growthLast 12 months | +29.2% | +49.4% |
| Total funding | $60.0M | $21.5M |
| Latest round | Series B | Series A |
| LinkedIn followers | 8,740 | 5,945 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Arzeda | Scala Biodesign |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 56/100 |
| Traction | 58/100 | 52/100 |
| Team | 70/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 23/100 | 34/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | C (64/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 39/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Arzeda | Scala Biodesign |
|---|---|---|
| CMS | Ghost | Wix |
| Frameworks | Angular | Not detected |
| Analytics | Not detected | Linkedin Insight |
| Open source | No | Yes |
Arzeda vs Scala Biodesign: common questions
Which is better, Arzeda or Scala Biodesign?
On our 0-100 score Arzeda rates higher (61/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Arzeda and Scala Biodesign compare on the numbers?
Arzeda leads on our overall score (61/100 against 56/100), agent readiness (64/100 against 45/100), domain rating (39/100 against 23/100), headcount (74 against 30), funding raised ($60.0M against $21.5M), LinkedIn following (8,740 against 5,945). Scala Biodesign leads on headcount growth (+49.4% against +29.2%).
Read the full Arzeda review and pricing or the Scala Biodesign review and pricing. You can also browse other Arzeda alternatives we track.